Pharmacodynamic effects of amikacin, ciprofloxacin and imipenem on growing and non-growing Escherichia coli and Pseudomonas aeruginosa  by Svensson, Erik et al.
ORIGINAL ARTICLE 
Pharmacodynamic effects of amikacin, ciprofloxacin and 
imipenem on growing and non-growing Escherichia coli and 
Pseudomonas aeruginosa 
Clin Microbiol Infect 1999; 5 :  140-148 
Erik Svensson', Hiikan Hanberger', Maud Nilsson' and 
Lennart E. Nilssonl 
'Departments of Clinical Microbiology and *Infectious Diseases, Faculty of Health Sciences, 
University Hospital, Linkoping, Sweden 
Objective: To compare control-related effective regrowth times (CERTs) and postantibiotic effects (PAEs) of amikacin, 
ciprofloxacin and imipenem on growing and non-growing Escherichia coli and Pseudomonas aeruginosa. 
Methods: CERTs and PAEs of amikacin, ciprofloxacin and imipenem were determined with bioluminescence assay of 
bacterial ATP and viable counts. 
Results: Negative viable count PAEs of amikacin and imipenem occurred on growing bacteria, but bioluminescence 
PAEs were positive. CERTs were equal with both methods. Amikacin and ciprofloxacin induced long, concentration- 
dependent CERTs on growing and non-growing cultures. Amikacin (32 mg/L) prevented regrowth of €. coliand induced 
a CERT of 6.0 h on F! aeruginosa; corresponding CERTs on non-growing bacteria were 3.4 h and 3.3 h, respectively. 
Ciprofloxacin (8 mg/L) prevented regrowth of both strains in growing cultures and induced CERTs of 5.1 h on non- 
growing €. coli and 13.3 h on F! aeruginosa. lmipenem induced a concentration-dependent CERT on growing bacteria 
and no CERT on non-growing cultures. lmipenem (16 mg/L) induced a CERT of 5.3 h on growing F! aeruginosa and 3.2 
h on E. coli. 
Conclusion: Amikacin and ciprofloxacin induced strong pharmacodynamic effects on growing and non-growing €. coli 
and /? aeruginosa, while imipenem was only effective on growing cultures. 
Key words: Control-related effective regrowth time, postantibiotic effect, amikacin, ciprofloxacin, imipenem, non- 
growing, Escherichia coli, Pseudomonas aeruginosa. 
INTRODUCTION 
Endocarditis, abscesses and infections at the sites of 
medical implants or indwelling catheters are difficult 
to treat successfully with antibiotics. This may be due 
to a decreased growth rate of the bacteria [l]. It has 
been proposed that this inability of antibiotics to kill 
biofilm bacteria is primarily a growth rate-related 
effect [Z]. P-Lactam antibiotics are unable to kill non- 
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growing bacteria, with the exception of imipenem, 
which is claimed to kill non-growing Gram-negative 
bacteria (31. Furthermore, quinolones and amino- 
glycosides have also been reported to kill non-grow- 
ing Gram-negative bacteria [4-61. 
All conventional susceptibility-testing methods, 
such as disk diffusion, Etest, and MIC determined on 
agar plates or in broth, are performed on growing 
bacterial cultures. In these tests, growth inhibition 
induced by the tested drug forms the basis for antibiotic 
susceptibility interpretation. With such methods, resis- 
tance cannot, of course, be detected in cultures that are 
already inhibited in their growth. 
The postantibiotic effect (PAE), which is the 
delayed regrowth after a brief exposure to drug, may be 
used for determining antibiotic dosing schedules. Since 
determination of PAE requires repeated quantifications 
of bacterial numbers and the viable count method is 
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very laborious, other methods for bacterial quantifi- 
cation have been used [7-101. However, the PAE results 
obtained with these methods differ, in particular on 
Gram-negative bacteria [7-101. To circumvent these 
methodological differences, we have used the control- 
related effective regrowth time (CERT), which is 
independent of the method used for bacterial quantifi- 
cation [10,11]. CERT is the time needed for the 
antibiotic-exposed culture to resume logarithmic growth 
and to return to the pre-exposure inoculum compared 
to the corresponding time for the control culture. We 
have previously studied CERTs of amikacin, imi- 
penem, ofloxacin, rifampicin and vancomycin on 
growing and non-growing Staphylococcus epidemidis 
[1 11. Only rifampin maintained a long CERT, and 
ofloxacin had a short CERT [ l l ]  on non-growing 
S. epiderrnidis. The other drugs induced no CERTs on 
non-growing bacteria [ l  I]. 
The aim of this study was to evaluate PAEs and 
CERTs of amikacin, ciprofloxacin and imipenem on 
growing and non-growing Escherichia coli ATCC 25922 
and Pseudornonas aeruginosa ATCC 27853. PAEs and 
CERTs were determined by bioluminescence of bac- 
terial ATP and by viable counts. 
MATERIALS AND METHODS 
Antibiotics 
Amikacin (Bristol Myers Laboratories, Blomfield, NJ, 
USA), ciprofloxacin (Bayer AG, Wuppertal, Germany) 
and imipenem (MSD International, Rahway, NJ, USA) 
were kindly supplied by the manufacturers. 
The antibiotic concentrations used in all experi- 
ments were the highest clinically achievable serum 
concentrations at  1 h after intravenous administration 
of amikacin (32 mg/L [12]), or ciprofloxacin (8 mg/L 
[13]), or at 2 h after intravenous administration of 
iniipenem (1 6 mg/L [ 121); the breakpoints for sensi- 
tivity were according to the Swedish Reference 
Group for Antibiotics (amikacin 8 mg/L, cipro- 
floxacin 1 mg/L, and imipenem 4 mg/L); and the 
MICs for each strain. 
MIC determinations 
Serial twofold dilutions of antibiotics were prepared 
in Mueller-Hinton broth (MHB) (BBL, Becton 
Dickinson Co., Cockeysville, Md, USA) supplemented 
with 50 mg Ca2+ and 25 mg M$+ per liter. From these 
dilutions, 0.5-mL aliquots were added to a series of test 
tubes. Bacteria from overnight cultures were diluted 
to reach a concentration of approximately 2X105 
CFU/mL, and 0.5-mL aliquots of these cultures were 
added to the test tubes, which were then incubated at  
37OC. Visible growth was recorded after 24 h. 
Bioluminescence assay of ATP 
Analytic equipment 
Light emission from the bioluminescence assay was 
measured in a 1250 Luminometer (LKB-Wallac, Turku, 
Finland) and recorded on a 1250 Display (LKB- 
Wallac). The extraction of intracellular bacterial ATP 
was performed in a LKI-Biocal 2073 incubator (LKB 
Products, Bromma, Sweden). 
Analytic reagents 
The firefly luciferin/luciferase enzyme system (ATP- 
monitoring reagent, Bio Orbit, Turku, Finland) was 
used in the assay ofATP. Apyrase, purified grade I (Sigma 
Chemical Co., St Louis, Mo, USA), was used to elim- 
inate extracellular ATP before the extraction of intra- 
cellular ATP. Other reagents were of analytic grade. 
Elimination of extracellular ATP 
A 100-pL sample from the culture was incubated for 
10 min at 37°C with 100 pL of solution consisting of 
0.04% apyrase in supplemented MHB for growing 
cultures and in phosphate-buffered saline (PBS) for 
non-growing cultures. 
Extraction of intracellular ATP 
After elimination of extracellular ATP, 50 pL of the 
apyrase-treated sample was pipetted into 500 pL of 
boiling 0.1 M Tris buffer, p H  7.75, containing 2 m M  
EDTA. After being heated for 90 s, the extracts were 
cooled before the assay of ATP. This procedure 
inactivated the apyrase and disrupted the bacterial cells, 
causing them to release their ATP. 
Luciferase assay of ATP 
Luciferase reagent (100 pL) was added to 550 pL of 
each extract and the light intensity was recorded. 
Calculation of assay results 
Sample ATP levels were calculated by using assays of 
standard amounts ofATP as a reference. Correction was 
made for background luminescence. Known amounts 
of ATP added to the extracts were used as internal 
standards in order to correct for inhibition of the 
luciferase reaction by the extracts. 
Culture conditions 
The bacterial density in overnight cultures of E .  coli 
ATCC 25922 and l? aeruginosa ATCC 27853 growing 
in MHB was assessed by bioluminescence assay of 
bacterial ATP. The cultures were diluted with MHB 
or, in order to stop growth, with PBS (i.e. NaCl 8 g, 
KC1 0.2 g, NaZHP04. 2H20 1.2 g, KH2P04 0.2 g, 
MgCl . 6H2O 0.21 g, CaCl 0.38 g, water to 1000 mL; 
p H  7.3), to reach a density of lo-* M ATP, which 
Clinical  M i c r o b i o l o g y  a n d  Infec t ion ,  Volume 5 Number 3, March 1999 142 
corresponds to lo7 CFU/mL [14]. In the PBS-diluted 
culture, there was 2-3% MHB. The PBS cultures were 
then incubated for 24 h. Samples of 1 mL. each of these 
cultures were added to tubes containing 10 pL of 
antibiotic solutions at different concentrations. The 
tubes containing amikacin and ciprofloxacin were 
incubated for 1 h and the tubes containing imipenem 
for 2 h, at 37OC. 
Determination of podantibiotic effect and control-related 
effective regrowth time 
The change in bacterial number during the antibiotic 
exposure (initial change) was assessed before and at the 
end of the antibiotic exposure with bioluminescence 
and viable count. All cultures were then diluted loM4 
with prewarmed MHB in order to eliminate anti- 
biotics. Regrowth was monitored each hour for 25 h 
in the diluted culture by the bioluminescence assay of 
bacterial ATP. 
The PAE was calculated from the regrowth curves 
using the equation PAE=TPAE-CP~, where TPAE is 
the time required for the bacterial population in the test 
culture to increase by lo4 after elimination of the drug, 
I 1 
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I I 
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and CPs is the correspondmg time for the control 
culture (Figure IA). The ATP levels in the drug- 
exposed cultures immediately after 10 000-fold dilution 
were below the detection limit. Therefore, the ATP 
was measured before dilution, and the values obtained 
(divided by lo4) were used as the starting values in these 
calculations. Normally, the PAE is calculated on the 
basis of the time taken for the bacterial culture to 
resume logarithmic growth and increase 10-fold [15]. 
Since the ATP concentrations after a 10000-fold 
dilution of drug-exposed culture were below the 
detection limit, we chose to use the time taken for 
bacterial numbers to increase by lo4, which we 
considered to be adequate, since the growth curves for 
drug-treated and untreated bacteria were parallel once 
growth had started [16]. 
CERT was also calculated from the growth curves 
using the equation CERT= TCERT- CCERT, where 
TCERT is the time required for the bacterial population 
in the test culture to resume logarithmic growth after 
elimination of drug by 10000-fold dilution and return 
to the pre-exposure inoculum. CCERT is the corres- 
pondmg time for the control culture (Figure IB) [10,11]. 
-14', I 1 I I I i 
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Time (h) 
Figure 1 Principles for determination of PAE and CERT. At the end of antibiotic exposure, the cultures were diluted lo4 
in MHB to eliminate the drug. Regrowth was monitored by bioluminescence assay of bacterial AT€? W, control culture; 0. 
drug-exposed culture; (A) PAE was calculated by the equation PAE= TPAE- CWS. (B) CERT was calculated by the equation 
CERT= TCERT- CCERT, 
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RESULTS 
MIC 
The MICs of amikacin, ciprofloxacin and ifipenem 
for E .  coli were 2 mg/L, 0.008 mg/L 2nd 0.25 mg/L, 
were 4 mg/L, 0.5 mg/L and 8 mg/L. 
PAEs and CERTs of antibiotics on growing Pseudmonas 
aeruginosa 
Growing I? aevtrginosa exposed to 8 mg/L (16XMIC) 
of ciprofloxacin did not regrow in broth after drug 
elimination (Figure 2; Table 1). There was a great 
difference in pm when measured with biolumin- 
escence and viable count, respectively (Figure 2A), 
respectively. The correspondmg MICS for I? aevtrginosa 
-2-1 
1 2 8 1 2 16 1 2 4 
Amikacin Ciprofloxacin lmipenem 
Antibiotic concentration ( x  MIC) 
-2-1 
1 2 8 1 2 16 1 2 4 
Am i kacin Ciprofloxacin I mi penem 
Antibiotic concentration (xMIC) 
Figure 2 Antibiotic effects on growing I? aeruginosa. PAE (A) and CERT (B) were determined with bioluminescence (dark 
bars) and viable count (light bars). NR, no regrowth. 
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Table 1 Control-related effective regrowth time (CERT) of growing and non-growing Psecrdornonus aeruginosa ATCC27853 
and E. coliATCC25922". 
Drug 
Growing culture Non-growing culture 
Concentration 
Bioluminescence Viable counts Bioluminescence Viable counts 
mg/L (X  MIC) Mean (h)k SD Mean (h) Mean (h)+ SD Mean (h) 
Pseudomonas aeruginosa ATCC 27853 
Amikacin 4 
8 
32 
Ciprofloxacin 0.5 
1 
8 
Imipenem 4 
8 
16 
Escherichia coli ATCC 25922 
Amikacin 2 
8 
32 
Ciprofloxacin 0.008 
1 
8 
Imipenem 0.25 
8 
16 
1 
2 
8 
1 
2 
16 
1 
2 
4 
1 
2 
16 
1 
125 
1000 
1 
32 
64 
1.4f0.8 
2.4k0.9 
6.0k0.1 
1.9f0.8 
4.6f0.6 
N R  
4.5f0.9 
5.6f1.6 
5.3k0.8 
1.6k0.5 
4.4f1.5 
NR 
1.7k0.2 
8.0b 
NR 
1.4f1.3 
4.2k2.8 
3.7' 
1.1 
2.2 
4.9 
1.9 
4.6 
NR 
4.1 
4.5 
4.7 
1.0 
3.5 
N R  
1.5 
12.2 
NR 
0.3 
4.3 
5.5 
0.6f0.1 
1.5kO.3 
3.3k0.8 
1.8k0.7 
4.0f0.7 
13.3k2.9 
0.3f0.1 
0.3k0.1 
0.2k0.3 
0.2f0.2 
1.8f1.3 
3.4k2.3 
0.3k0.2 
5.3f0.6 
5.1kO.2 
O.Ok0.0 
0.0k0.1 
0.1k0.2 
0.6 
1.4 
3.7 
1.5 
3.9 
13.2 
0.4 
0.4 
0.4 
0.6 
2.8 
5.0 
0.4 
5.6 
5.1 
0.0 
0.0 
0.0 
"Three experiments were performed for all antibiotics with bioluminescence; two experiments with viable counts for amikacin and 
ciprofloxacin, and one for imipenem. 
bRegrowth in two experiments of three. 
"Regrowth in one experiment. 
NR, no regrowth. 
whereas the difference in CERT was small (Figure 2B; 
Table 1). In these cultures, the initial decrease in ATP 
was weak (50.4 loglo M ATP), whereas the decrease 
in viability was much stronger (53.4 loglo CFU/mL) 
and concentration dependent for amikacin and 
ciprofloxacin. CERT was concentration dependent for 
amikacin and ciprofloxacin (Figure 2B; Table 1). PAE 
induced by amikacin and by imipenem was negative at 
higher concentrations when measured with viable 
count, but PAE with bioluminescence was always 
positive and was almost as long as the corresponding 
CERT (Figure 2). PAE induced by ciprofloxacin was 
short with viable count, but the corresponding PAE 
with bioluminescence was long and almost equal to 
CERT (Figure 2). 
PAEs and CERTs of antibiotics on non-growing 
Pseudomonas aeruginosa 
Amikacin and ciprofloxacin induced concentration- 
dependent PAEs and CERTs on non-growing 
I? aeruginosa (Figure 3; Table I), but imipenem caused 
no PAE or CERT (Figure 3; Table 1). There were 
differences between PAEs with bioluminescence and 
those with viable count, but the differences were 
smaller than in the growing cultures (Figure 3). No 
change in ATP was seen during antibiotic exposure, but 
there was a great change in viability (14.0 loglo 
CFU/mL), which was concentration dependent for 
amikacin and ciprofloxacin. PAEs with biolumin- 
escence were almost equal to the corresponding 
CERTs (Figure 3). No lfference was observed in 
CERT values obtained with bioluminescence and 
viable count (Figure 3B; Table 1). 
PAEs and CERTs of antibiotics on growing fscherichia coli 
Growing E.  coli cultures exposed to 32 mg/L 
(8xMIC) of amikacin or 8 mg/L (1000xMIC) of 
ciprofloxacin did not regrow in broth after antibiotic 
elimination (Table 1). In the other cultures, the 
differences in PAEs measured with bioluminescence 
and viable count were great, whereas the differences in 
CERTs were small (Table 1). The initial decrease in 
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Figure 3 Antibiotic effects on non-growing P aertrginosa. PAE (A) and CERT (B) were determined with bioluminescence 
(dark bars) and viable count (light bars). 
ATP was generally weak (50.5 loglo M ATP), but the 
initial decrease in viability was strong (13.8 loglo 
CFU/mL). PAE induced by all drugs was almost 
always negative with viable count (Table 1). PAEs with 
bioluminescence were positive, and were almost as 
long as the corresponding CERTs (Table 1). CERTs 
induced by amikacin or by imipenem were 
concentration dependent (Table 1). 
PAEs and CERTs of antibiotics on non-growing 
Fscherichia coli 
Amikacin and ciprofloxacin induced concentration- 
dependent PAEs and CERTs on non-growing E. coli, 
but the effects of imipenem were weak (Table 1). PAEs 
determined with bioluminescence were longer than 
PAEs determined with viable count in cultures exposed 
to amikacin or ciprofloxacin, but the difference was 
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smaller than in growing cultures (Table 1). There was 
no initial decrease in ATP, but the initial decrease in 
viability was 52.4 loglo CFU/mL.. The initial decrease 
in viability was concentration dependent for amikacin 
and ciprofloxacin. PAEs with bioluminescence were 
almost equal to the corresponding CERTs (Table 1). 
CERTs determined with bioluminescence and viable 
count were equal (Table 1). 
Correlation of PAE and CERT 
PAEs and CERTs on growing and non-growing 
bacteria obtained with bioluminescence and viable 
count were compared with linear regression analysis. 
There was a strong correlation between CERTs 
obtained with bioluminescence and those obtained 
with viable count (r=0.941), but a weak correlation 
between the corresponding PAEs ( ~ 0 . 6 6 9 )  (Figure 4). 
DISCUSSION 
In the present study, the length of the PAE was 
dependent on the method used for bacterial 
quantification (Table 1; Figures 2 and 3). The number 
of bacteria at the end of a brief antibiotic exposure is 
used in the PAE calculation (Figure 1) [7], and these 
estimates of bacterial numbers may vary with the 
method used [7,8,10]. The negative PAE with viable 
count (Figures 2 and 3) can be explained by an 
exaggeration of the initial decrease of bacteria in broth. 
PAE determinations with viable count include incuba- 
tion on agar plates before calculation of CFU/mL in 
(A) 
16 
12 
P 
v 
m 
the samples taken from the broth cultures. During this 
incubation, fragile cells that would survive in broth may 
not form colonies on the agar surface. In the same 
cultures, PAE determinations with bioluminescence 
may underestimate the change in bacterial ATP at the 
end of antibiotic exposure. The very small changes in 
ATP in the samples reflect the intracellular ATP level 
at the time the sample is taken and do not reflect any 
delayed breakdown of ATP in the damaged bacteria. 
These methodological dinlculties are avoided if the 
calculations of delayed regrowth of antibiotic-exposed 
bacteria include only bacterial enumerations made 
before the antibiotic is added and during logarithmic 
regrowth after the drug is eliminated. In previous 
papers, we used CERT to circumvent this methodo- 
logical problem [10,11]. CERT is calculated from the 
pre-exposure inoculum and the regrowing bacteria 
after antibiotic elimination, and is therefore independ- 
ent of the methods used for bacterial quantification 
[10,11] (Figures 1-4). This makes it possible to choose 
any convenient method for bacterial quantification in 
the estimation of CERT and still get comparable 
results. 
Many of the events taking place during starvation 
have been studied in the marine Mbrio [17,18]. A great 
number of events occur as the growing Vibrio is placed 
in the starvation medium. Initially, there is rapid 
downregulation of the synthesis of RNA, proteins and 
peptidoglycan [19,20], and intracellular proteolysis 
1211. Later during the starvation (after 20 min and up 
to 5 h), macromolecular synthesis partially recovers. 
I 16 t r =0.941 // / 
1 
-8 -4 0 4 8 12 16 
PAE with viable count fh) 
-8 -8 1 -8 -4 0 4 8 12 16 
CERT with viable count (h) 
Figure 4 Correlation of PAE (A) and CERT (!3) on growing and non-growing E .  coli and F! aeruginosa exposed to 
amikacin, ciprofloxacin or imipenem determined with viable count and bioluminescence. 
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During the third phase, macromolecular synthesis and 
protein content decrease [2 11. Meanwhile, resistance to 
UV light increases [22] and mRNA half-lives are 
prolonged [23]. Furthermore, there is synthesis of 
starvation-specific proteins during starvation [19]. 
Amikacin induced long PAEs and CERTs on 
growing as well as on non-growing E.  coli and l? 
a e r u < + m  (Table 1). The PAE and CERT of the non- 
growing cultures were slightly decreased compared to 
growing cultures (Table 1; Figures 2 and 3). Our results 
on amikacin are in agreement with those reported by 
Eng et a1 [3] who found that gentamicin was strongly 
bactericidal on growing E. coli and P aeriigiriosa and had 
a decreased but still present bactericidal effect on non- 
growing cultures. In that study, growing bacteria were 
transferred to starvation medium and were exposed to 
antibiotics for 24 h, when viable counting was 
performed [4]. In a previous study of ours, amikacin 
induced a long CERT on growing S. epidermidis, but 
no CERT on non-growing bacteria [ l  11. 
In the present study, ciprofloxacin had strong 
effects on both growing and non-growing cultures of 
E. coli and P aeruginosa. Growing cultures did not 
regrow in broth when they were exposed to the highest 
concentrations of ciprofloxacin. In the non-growing 
cultures, ciprofloxacin induced long CERTs. These 
results are in agreement with previous studies in which 
ciprofloxacin was active on non-growing Gram- 
negative bacteria [4,5] and L-ofloxacin killed non- 
growing E. coli [6]. In these studies, non-growing 
bacteria were exposed to antibiotics for 5 h [5] or 24 h 
[4], and the bacterial numbers were monitored with 
viable counts. Previously, we showed that ofloxacin 
induced a long CERT (10 h) on growing cultures of 
S. epidermidis, but a short CERT (1.2 h) on non- 
growing S. epidermidis [l 11. 
The effects of imipenem on E. coli and I? aeruginosa 
cultures were different in growing and non-growing 
cultures. Imipenem induced no CERT on non- 
growing bacteria (Table 1; Figure 3B). Tuomanen [3] 
reported that imipenem can kill non-growing bacteria. 
However, this is true only when the pre-starvation in 
lysine-free medium was less than approximately 2 h [3]. 
In our previous study, imipenem induced a CERT (2.8 
h) on growing S. epidermidis, but did not induce a 
CERT in non-growing cultures [ 1 11. 
We believe that the changes in bacterial metabo- 
lism as a response to starvation are responsible for the 
loss of effect of antibiotics against non-growing bacteria 
[17-231. The drugs that will affect non-growing 
bacteria are those that interfere with the remaining 
syntheses. The antibiotics will have toxic effects on the 
bacteria which depend on the stage of starvation at 
which they are administered. 
In conclusion, this study shows that CERT is 
independent of the method used for bacterial quantifi- 
cation. CERT may be used for studies on both growing 
and non-growing bacteria. Amikacin and cipro- 
floxacin, but not imipenem, have strong pharmaco- 
dynamic effects on growing as well as non-growing 
l? aevrginosa and E. coli. This may have an impact when 
treating infections caused by bacteria with suboptimal 
growth conditions. 
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